NP0333603 | paraphaeolactone C1 | | | C17H16O6
316.3090 Da 316.09469 Da | 1H NMR Spectrum (1D, 500 MHz, CDCL3, experimental) | 1H NMR Spectrum (1D, 500 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | 13C NMR Spectrum (1D, 126 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) |
|
NP0333604 | paraphaeolactone C2 | | | C17H16O6
316.3090 Da 316.09469 Da | 1H NMR Spectrum (1D, 500 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | 13C NMR Spectrum (1D, 126 MHz, CDCL3, experimental) | 1H NMR Spectrum (1D, 500 MHz, CDCL3, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) |
|
NP0333605 | triantaspirol B triacetate | | | C36H30O11
638.6250 Da 638.17881 Da | |
NP0333606 | triantaspirol C triacetate | | | C36H30O11
638.6250 Da 638.17881 Da | |
NP0333607 | CJ-12,372 triacetate | | | C26H22O8
462.4540 Da 462.13147 Da | |
NP0333608 | cladoic acid | | | C21H32O5
364.4820 Da 364.22497 Da | 1H NMR Spectrum (1D, 500 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) |
|
NP0333609 | (S)-MTPA ester 4a | | | C32H41F3O7
594.6680 Da 594.28044 Da | |
NP0333610 | (R)-MTPA ester 4a | | | C32H41F3O7
594.6680 Da 594.28044 Da | |
NP0333611 | Maduramycin A | | | C43H61NO21
927.9470 Da 927.37361 Da | 1H NMR Spectrum (1D, 400.152470926, C2D6OS, simulated) | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 400 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) |
|
NP0333612 | Maduramycin B | | | C42H59NO21
913.9200 Da 913.35796 Da | 1H NMR Spectrum (1D, 600.133705802, C2D6OS, simulated) | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) |
|
NP0333613 | Maduramycin C | | | C38H55NO21
861.8440 Da 861.32666 Da | 1H NMR Spectrum (1D, 400.152470926, C2D6OS, simulated) | 13C NMR Spectrum (1D, 101 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 101 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 400 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) |
|
NP0333614 | Maduramycin D | | | C20H22O2
294.3940 Da 294.16198 Da | 1H NMR Spectrum (1D, 400.152470926, CDCl3, simulated) | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 400 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) |
|
NP0333615 | Maduramycin E | | | C19H20O2
280.3670 Da 280.14633 Da | 1H NMR Spectrum (1D, 400.152470926, CDCl3, simulated) | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 400 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) |
|
NP0333616 | sucurchalasin A | | | C40H53NO9S
723.9200 Da 723.34410 Da | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) |
|
NP0333617 | sucurchalasin B | | | C40H53NO9S
723.9200 Da 723.34410 Da | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) |
|
NP0333621 | 2-Aminobenzamide-actiphenol | | | C22H23N3O5
409.4420 Da 409.16377 Da | |
NP0333622 | Salamandamide A | | | C21H39N3O6
429.5580 Da 429.28389 Da | 13C NMR Spectrum (1D, 101 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 400 MHz, C2D6OS, experimental) | [1H, 15N] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) | [1H, 15N] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 101 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) |
|
NP0333646 | Acroamine A | | | C10H12N8
244.2620 Da 244.11849 Da | 1H NMR Spectrum (1D, 600.314502325, CD3OD, simulated) | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | [1H, 15N] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) |
|
NP0333647 | Acroamine A1 | | | C16H25N8
329.4310 Da 329.21967 Da | 1H NMR Spectrum (1D, 600.314502325, CD3OD, simulated) | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 15N] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) |
|
NP0333648 | Acroamine A2 | | | C15H23N8
315.4040 Da 315.20402 Da | 1H NMR Spectrum (1D, 600.314502325, CD3OD, simulated) | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 15N] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) |
|
NP0333649 | Acroamine A3 | | | C14H21N8
301.3770 Da 301.18837 Da | 1H NMR Spectrum (1D, 600.314502325, CD3OD, simulated) | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 15N] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) |
|
NP0333650 | Acroamine A4 | | | C16H26N8
330.4390 Da 330.22695 Da | 1H NMR Spectrum (1D, 600.314502325, CD3OD, simulated) | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [13C, 15N] NMR Spectrum (2D, 151 MHz, CD3OD, experimental) |
|
NP0333651 | Acroamine A5 | | | C17H27N9
357.4650 Da 357.23784 Da | 1H NMR Spectrum (1D, 600.314502325, CD3OD, simulated) | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) |
|
NP0333652 | Acroamine A6 | | | C10H11BrN8
323.1580 Da 322.02900 Da | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) |
|
NP0333653 | Acroamine A7 | | | C10H10Br2N8
402.0540 Da 399.93952 Da | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) |
|